1. Home
  2. DARE

DARE

Dare Bioscience Inc.

Logo Dare Bioscience Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Founded: N/A Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 47.2M IPO Year: N/A
Target Price: $6.00 AVG Volume (30 days): 362.7K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.35 EPS Growth: N/A
52 Week Low/High: $0.27 - $1.10 Next Earning Date: 05-09-2024
Revenue: $2,807,885 Revenue Growth: -71.92%
Revenue Growth (this year): 152.93% Revenue Growth (next year): 379.22%

Share on Social Networks: